The relationship between platinum drug resistance and epithelial–mesenchymal transition
Author:
Publisher
Springer Science and Business Media LLC
Subject
Health, Toxicology and Mutagenesis,Toxicology,General Medicine
Link
http://link.springer.com/content/pdf/10.1007/s00204-016-1912-7.pdf
Reference114 articles.
1. Arumugam T, Ramachandran V, Fournier KF et al (2009) Epithelial to mesenchymal transition contributes to drug resistance in pancreatic cancer. Cancer Res 69(14):5820–5828. doi: 10.1158/0008-5472.CAN-08-2819
2. Banyard J, Bielenberg DR (2015) The role of EMT and MET in cancer dissemination. Connect Tissue Res 56(5):403–413. doi: 10.3109/03008207.2015.1060970
3. Baribeau S, Chaudhry P, Parent S, Asselin E (2014) Resveratrol inhibits cisplatin-induced epithelial-to-mesenchymal transition in ovarian cancer cell lines. PLoS ONE 9(1):e86987. doi: 10.1371/journal.pone.0086987
4. Bieller A, Pasche B, Frank S et al (2001) Isolation and characterization of the human forkhead gene FOXQ1. DNA Cell Biol 20(9):555–561. doi: 10.1089/104454901317094963
5. Boulikas T, Vougiouka M (2003) Cisplatin and platinum drugs at the molecular level (review). Oncol Rep 10(6):1663–1682
Cited by 63 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Desmethylclomipramine triggers mitochondrial damage and death in TGF-β-induced mesenchymal type of A549 cells;Life Sciences;2024-08
2. Dynamics of epithelial–mesenchymal plasticity driving cancer drug resistance;Cancer Pathogenesis and Therapy;2024-07
3. Drug resistance mechanisms and treatment strategies mediated by Ubiquitin-Specific Proteases (USPs) in cancers: new directions and therapeutic options;Molecular Cancer;2024-05-03
4. Understanding the Role of Connexins in Hepatocellular Carcinoma: Molecular and Prognostic Implications;Cancers;2024-04-17
5. lncRNA-microRNA axis in cancer drug resistance: particular focus on signaling pathways;Medical Oncology;2024-01-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3